Cyclacel Pharmaceuticals, Inc. (CYCC) Reports First Quarter 2013 Financial Results
5/14/2013 9:55:03 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
BERKELEY HEIGHTS, N.J., May 13, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today reported its financial results and business highlights for the first quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.